Manufacturing, Packaging & Detailing Market Research Reports & Industry Analysis
Current Good Manufacturing Practices (cGMPs) refers to the regulations enforced by the FDA. The cGMPs provide for systems that assure proper design, monitoring, and control of manufacturing processes and facilities.
Adherence to the cGMP regulations assures the identity, strength, quality, and purity of drug products by requiring that manufacturers of medications adequately control manufacturing operations. This includes establishing strong quality management systems, obtaining appropriate quality raw materials, establishing robust operating procedures, detecting and investigating product quality deviations, and maintaining reliable testing laboratories. This formal system of controls at a pharmaceutical company, if adequately put into practice, helps to prevent instances of contamination, mix-ups, deviations, failures, and errors. This assures that drug products meet their quality standards.
The cGMP requirements were established to be flexible in order to allow each manufacturer to decide individually how to best implement the necessary controls by using scientifically sound design, processing methods, and testing procedures. The flexibility in these regulations allows companies to use modern technologies and innovative approaches to achieve higher quality through continual improvement.
- Use of RFID in serialized unique packaging numbering to authenticate and check for recall/expiry status.
- Use of X-ray and metal detection systems to detect glass, stone, bone, rubber and other contaminants
- Use of checkweighers and sorters
- Use of baggers capable of handling, opening and sealing bags manufactured from specialist sterile films and papers.
- Use of quality control labeling systems
It is important to note that cGMPs are minimum requirements. Many pharmaceutical manufacturers are already implementing comprehensive, modern quality systems and risk management approaches that exceed these minimum standards. This is important because a consumer cannot detect through smell, touch, or sight if a drug product is safe or if it will work.
Manufacturing, Packaging & Detailing Industry Research & Market Reports
-
Pharmaceutical Preparation Manufacturing - 2024 U.S. Market Research Report with Updated Recession Risk Forecasts
... the United States with over 100 data sets covering 2015-2028. This 63-page Kentley Insights report is packed with insightful data sets and forecasts to give you a comprehensive understanding of the industry including historical and ... Read More
-
Medicinal and Botanical Manufacturing - 2024 U.S. Market Research Report with Updated Recession Risk Forecasts
... industry in the United States with over 100 data sets covering 2015-2028. This 63-page Kentley Insights report is packed with insightful data sets and forecasts to give you a comprehensive understanding of the industry including ... Read More
-
Pharmaceutical and Medicine Manufacturing - 2024 U.S. Market Research Report with Updated Recession Risk Forecasts
... industry in the United States with over 100 data sets covering 2015-2028. This 63-page Kentley Insights report is packed with insightful data sets and forecasts to give you a comprehensive understanding of the industry including ... Read More
-
Biological Product (except Diagnostic) Manufacturing - 2024 U.S. Market Research Report with Updated Recession Risk Forecasts
... of the industry in the United States with over 100 data sets covering 2015-2028. This 63-page Kentley Insights report is packed with insightful data sets and forecasts to give you a comprehensive understanding of the ... Read More
-
Contract Research Organizations in the US - Industry Market Research Report
... for Food and Drug Administration (FDA) approval. An explosion in research and development investment, frustratingly high clinical trial costs and an uptick in patent expirations have driven pharmaceutical companies to outsource clinical trial management. These ... Read More
-
2024 Global: Other Acylic Monoamines And Their Derivatives; Salts Thereof Products-Manufacturing Forecast (2030) report
... and regional data for the period 2019 through 2030. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions ... Read More
-
2024 Global: Glass Containers For Pharmaceutical Products Of A Nominal Capacity < 2,5 Litres Products-Manufacturing Forecast (2030) report
... proprietary economic models. Our forecasts project the product market size nationally and by regions for 2018 to 2029 using regression analysis in our modeling. and Perry/Hope is the only market research publisher that utilizes both ... Read More
-
2024 Global: Laboratory, Hygienic Or Pharmaceutical Glassware Whether Or Not Graduated Products-Manufacturing Forecast (2030) report
... projected growth/decline and regional data for the period 2019 through 2030. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and ... Read More
-
Pharmaceuticals Packing and Labelling Services in Australia - Industry Market Research Report
... manufacturing operations. Industry operators have continued to benefit from manufacturers perceiving pharmaceutical packaging as integral to the drug delivery system. As competition has increased and life cycles have shortened for pharmaceutical manufacturers, pharmaceutical companies have ... Read More
-
Shanghai Green Valley Pharmaceutical Co., Ltd. - Strategic SWOT Spotlight
... business operations. It provides a Snapshot of the company's position in the industry compared to competitors. The report includs key executives, products and services, ESG spotlight, Corporate Strategy, Business Description, Helicopter view of SWOT Analysis, ... Read More
-
Pharmaceutical Contract Manufacturing Market: Industry Trends and Global Forecasts, Till 2035
... In the rapidly evolving pharmaceutical landscape, small molecule drugs continue to play a pivotal role in shaping innovation and development. Currently, small molecules account for 90% of all pharmaceutical drugs, even as biologics have gained ... Read More
-
Pharmerging Market Size, Share & Trends Analysis Report By Product (Pharmaceutical, Healthcare), By Economy (Tier-1, Tier-2), By Indication (Lifestyle Disease, Infectious Disease), By Region, And Segment Forecasts, 2024 - 2030
... The global pharmerging market size is expected to reach USD 2.08 trillion in 2030 and is projected to grow at a CAGR of 2.6% from 2024 to 2030. This market is expected to grow due ... Read More
-
Non-opioid Pain Treatment Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2024 – 2032
... a CAGR of 7.3% from 2024 to 2032. This growth can be attributed to the rising incidence of chronic pain conditions and heightened concerns over opioid addiction and its risks. With a growing number of ... Read More
-
ePedigree Software
... at a CAGR of 17.4% over the analysis period 2023-2030. On-Premise Deployment, one of the segments analyzed in the report, is expected to record a 16.6% CAGR and reach US$4.6 Billion by the end of ... Read More
-
Chemotherapy-induced Nausea and Vomiting Drugs
... is expected to reach US$5.1 Billion by 2030, growing at a CAGR of 5.1% over the analysis period 2023-2030. Serotonin Receptor Antagonist, one of the segments analyzed in the report, is expected to record a ... Read More
-
Biotechnology / Pharmaceutical Services Outsourcing
... is expected to reach US$102.2 Billion by 2030, growing at a CAGR of 5.5% over the analysis period 2023-2030. Consulting Services, one of the segments analyzed in the report, is expected to record a 5.4% ... Read More
-
Bioburden Testing
... growing at a CAGR of 9.8% over the period 2023-2030. Bioburden Testing Consumables, one of the segments analyzed in the report, is expected to record 10.2% CAGR and reach US$1.3 Billion by the end of ... Read More
-
Empty Capsules
... at a CAGR of 5.7% over the analysis period 2023-2030. Gelatin Capsules, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$3.5 Billion by the end of ... Read More
-
Carglumic Acid
... at a CAGR of 5.3% over the analysis period 2023-2030. Orally Disintegrating Tablets, one of the segments analyzed in the report, is expected to record a 5.9% CAGR and reach US$105.6 Million by the end ... Read More
-
Fill Finish Manufacturing
... by 2030, growing at a CAGR of 8.6% over the analysis period 2023-2030. for Fill Finish Manufacturing Consumables, one of the segments analyzed in the report, is expected to record a 9.9% CAGR and reach ... Read More
-
Non-alcoholic Steatohepatitis (NASH)
... by 2030, growing at a CAGR of 55.3% over the analysis period 2023-2030. Vitamin E & Pioglitazone Drug Type, one of the segments analyzed in the report, is expected to record a 45.5% CAGR and ... Read More
-
Lyophilization Equipment and Services
... reach US$10.6 Billion by 2030, growing at a CAGR of 6.8% over the analysis period 2023-2030. Tray Lyophilizers, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach ... Read More
-
Sanitary Valves
... at a CAGR of 3.4% over the analysis period 2023-2030. Control Valves, one of the segments analyzed in the report, is expected to record a 3.9% CAGR and reach US$223.4 Million by the end of ... Read More
-
Microencapsulation
... of 12.5% over the analysis period 2023-2030. Pharmaceutical & Healthcare Products Application, one of the segments analyzed in the report, is expected to record a 13.7% CAGR and reach US$13.2 Billion by the end of ... Read More
-
Benign Prostatic Hyperplasia (BPH) Drugs
... is expected to reach US$11.0 Billion by 2030, growing at a CAGR of 5.7% over the analysis period 2023-2030. Alpha-Blockers Drugs, one of the segments analyzed in the report, is expected to record a 6.0% ... Read More